Patents by Inventor Josef Miller

Josef Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8927528
    Abstract: A composition to be administered to a mammal for treating hearing loss is disclosed herein. The composition consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. The composition optionally includes a withanolide and/or resveratrol. The vitamin A, vitamin C, vitamin E, and the vasodilator comprising magnesium provides an additive effect that is equal to or greater than a sum of the effects of the individual components.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: January 6, 2015
    Assignee: The Regents of the University of Michigan
    Inventors: Josef Miller, Colleen LePrell, Jochen Schact, Diane Prieskorn
  • Patent number: 8338397
    Abstract: A method of treating side effects of antibiotic treatment includes the step of internally administering an antibiotic that is capable of inducing hearing loss in a mammal. The method further includes the step of internally administering a composition to the mammal in conjunction with administration of the antibiotic. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, vitamin E, vitamin C, and a vasodilator comprising magnesium. The combination of vitamins and the vasodilator comprising magnesium, in the biologically effective amounts, provides an effective treatment for treating side effects of antibiotic treatment.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: December 25, 2012
    Assignee: The Regents of the University of Michigan
    Inventor: Josef Miller
  • Patent number: 8338398
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: December 25, 2012
    Assignee: The Regents of the University of Michigan
    Inventors: Josef Miller, Colleen LePrell, Jochen Schact, Diane Prieskorn
  • Publication number: 20110280964
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.
    Type: Application
    Filed: April 21, 2011
    Publication date: November 17, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Josef Miller, Colleen LePrell, Jochen Schacht, Diane Prieskorn
  • Patent number: 8053424
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: November 8, 2011
    Assignee: The Regents of the University of Michigan
    Inventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
  • Patent number: 7951845
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.
    Type: Grant
    Filed: January 17, 2007
    Date of Patent: May 31, 2011
    Assignee: The Regents of the University of Michigan
    Inventors: Josef Miller, Colleen LePrell, Jochen Schacht, Diane Prieskorn
  • Publication number: 20100305075
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.
    Type: Application
    Filed: July 19, 2010
    Publication date: December 2, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
  • Patent number: 7786100
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: August 31, 2010
    Assignee: The Regents of the University of Michigan
    Inventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
  • Publication number: 20100215746
    Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.
    Type: Application
    Filed: March 5, 2010
    Publication date: August 26, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
  • Publication number: 20100203169
    Abstract: A method of treating side effects of antibiotic treatment includes the step of internally administering an antibiotic that is capable of inducing hearing loss in a mammal. The method further includes the step of internally administering a composition to the mammal in conjunction with administration of the antibiotic. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, vitamin E, vitamin C, and a vasodilator comprising magnesium. The combination of vitamins and the vasodilator comprising magnesium, in the biologically effective amounts, provides an effective treatment for treating side effects of antibiotic treatment.
    Type: Application
    Filed: April 15, 2010
    Publication date: August 12, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventor: Josef Miller
  • Patent number: 7700134
    Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: April 20, 2010
    Assignee: The Regents of the University of Michigan
    Inventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
  • Publication number: 20070219167
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.
    Type: Application
    Filed: March 20, 2006
    Publication date: September 20, 2007
    Inventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
  • Publication number: 20070165870
    Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.
    Type: Application
    Filed: January 17, 2007
    Publication date: July 19, 2007
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Josef Miller, Colleen LePrell, Jochen Schacht, Diane Prieskorn
  • Patent number: 6634414
    Abstract: A pressure die casting machine is provided for processing fused metals in which the die locking unit is mounted adjustably on a lifting frame that can be vertically raised or lowered to adapt the die locking unit to the casting nozzle via lever sets and a common mechanical adjusting device for these lever sets. This arrangement achieves a space-saving arrangement with a simplified design.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: October 21, 2003
    Assignee: Oskar Frech GmbH & Co.
    Inventor: Josef Miller
  • Publication number: 20030180388
    Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.
    Type: Application
    Filed: January 16, 2003
    Publication date: September 25, 2003
    Applicant: The Regents of the University of Michigan
    Inventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
  • Publication number: 20020185246
    Abstract: A pressure die casting machine is provided for processing fused metals in which the die locking unit is mounted adjustably on a lifting frame that can be vertically raised or lowered to adapt the die locking unit to the casting nozzle via lever sets and a common mechanical adjusting device for these lever sets. This arrangement achieves a space-saving arrangement with a simplified design.
    Type: Application
    Filed: June 7, 2002
    Publication date: December 12, 2002
    Applicant: Oskar Frech GmbH + Co.
    Inventor: Josef Miller